Skip to main content

Lisa Peraza

Chief Accounting Officer

Heron Therapeutics, Inc. (HRTX)

Equibles does not estimate personal net worth.

Get an email with a short summary when Heron Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get HRTX alerts

About Lisa Peraza

Lisa Peraza is recorded as Chief Accounting Officer at Heron Therapeutics, Inc. (HRTX) since October 13, 2020. The newest filing on record that lists Lisa Peraza as Chief Accounting Officer at Heron Therapeutics, Inc. (HRTX) is dated May 1, 2023. The proxy statement of Heron Therapeutics, Inc. reports total compensation of $796,755 for Lisa Peraza in fiscal 2021, including a base salary of $339,900. Disclosed compensation is on record for 2 fiscal years. Heron Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Heron Therapeutics, Inc. includes Craig Collard (CEO and Board Member), Adam Morgan (Chairman and Board Member), Ira Duarte (CFO and Chief Accounting Officer) and 7 others.

Affiliation history

Company network

Leadership on record at Heron Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Heron Therapeutics, Inc. (HRTX) $339,900 $796,755
2020 Heron Therapeutics, Inc. (HRTX) $328,805 $1,578,739

Recent activity

No call appearances or filed executive changes recorded yet.